Molecule intelOpportunity: Moderate0

Erythropoietin

14 brands · 5 companies · product forms

Opportunity snapshot

Launch attractiveness
45
Market saturation
15
Price room
100
Regulatory risk
0
14
brands
5
companies
Rs 9,949.62
median price
26
price points
2,183.99x
price spread
90
confidence %

Who competes here

Top companies by brand count · leader share 29%

3 brands · 21%
2 brands · 14%
1 brands · 7%

Price room

Across observed sources and strengths
CheapestRs 617.5
MedianRs 9,949.62
Most expensiveRs 1,348,616.25
Spread2,183.99×
Sources: DRAP-official, DVAGO

max/min price ratio 2183.99x across 26 trusted points (Rs 617.5-1348616.25). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Why this score

Launch attractiveness

40% supply-gap(12) + 25% price-variation(100) + 20% low-competition(85) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

5 canonical companies and 14 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 2183.99x across 26 trusted points (Rs 617.5-1348616.25). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.